The Makers of LISTERINE(R) Antiseptic Unveil New Docummercial Narrated by Neil Patrick Harris Benefiting America's Toothfairy(R)

View "This Is Your Mouth" at and Share It with Friends via Facebook(R) and Twitter(R)

MORRIS PLAINS, N.J., May 18 /PRNewswire/ -- The makers of LISTERINE® Antiseptic introduce "This Is Your Mouth," a docummercial narrated by award-winning actor Neil Patrick Harris (CBS's How I Met Your Mother).  By blending pop culture with science and a good dose of humor, this fast-paced video takes a closer look at the potential effects of rapidly multiplying bacteria in the mouth and illustrates how LISTERINE® Antiseptic destroys the millions of germs that are left behind from brushing alone to deliver the deepest clean.* Viewers will also explore when the product was first formulated in 1879 and get rare glimpses of retro advertisements.  Most importantly, each time the documentary is viewed at, a $1.00 donation** will go to National Children's Oral Health Foundation®: America's Toothfairy®.***

To view the multimedia assets associated with this release, please click:

"I never realized how much goes on 'behind the scenes' in our mouths, and that brushing and flossing alone isn't enough to keep germs at bay," said Neil Patrick Harris.  "But more importantly, I'm excited that by viewing this documentary on the website, donations will be made to National Children's Oral Health Foundation, a very worthwhile organization.  Children across the country need to spend more time on the playground and less time with a toothache!"

"This Is Your Mouth" takes viewers on a journey inside the mouth and examines the potential effects of the millions of bacteria that dwell there.  Watch and learn from leading dental professionals and scientists how bacteria multiply and collect in the mouth to form a thick layer called plaque biofilm, which is more harmful than free-flowing bacteria and may increase the potential for bad breath and gingivitis. If left untreated, gingivitis can lead to greater health problems. ****

"Plaque is not a simple matter and there is more to be concerned about than meets the eye.  We all need to understand the effects of the plaque biofilm," said Marcelo Araujo, D.D.S., Ph.D., Associate Director, Scientific & Professional Affairs, Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc.  "This docummercial will educate viewers on the important role that rinsing plays in fighting the plaque biofilm.  The four essential oils in LISTERINE® Antiseptic are proven to penetrate the biofilm to deliver the deepest clean for the healthiest mouth."*  

To view the short documentary and share it with friends via Facebook® and Twitter®, watch a making of the video with Neil Patrick Harris and to download specialty wallpaper, log onto  To learn more about America's Toothfairy® or to adopt the oral care of a child in need, visit

* Among nationally branded over-the-counter anti gingivitis mouth rinses

** Up to $15,000

*** Downloading "This is Your Mouth" will not trigger a donation in the following states: Alabama, Maine, Massachusetts, and South Carolina.

The third-party trademarks used herein are trademarks of their respective owners.

**** Emerging science suggests an association between periodontitis (advanced gum disease) and broader health problems, but a cause and effect relationship has not been established. LISTERINE® Antiseptic is indicated to help prevent or reduce plaque and gingivitis. It is not indicated for periodontitis or other diseases.

About LISTERINE® Antiseptic

LISTERINE® Antiseptic is the number one dentist-recommended brand of over-the-counter antimicrobial mouthrinse and the only nationally branded over-the-counter antimicrobial mouthrinse that has earned the ADA Seal of Acceptance. First offered for sale in 1879, first marketed for oral hygiene in 1895, and made today by Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc., LISTERINE® Antiseptic contains a fixed combination of four essential oils and is clinically proven to kill germs that cause plaque, gingivitis and bad breath. To learn more about LISTERINE® Antiseptic and to further explore the mouth-body connection, visit

Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. 

Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. is a leader in the consumer oral health and whitening market with LISTERINE® Antiseptic Mouthwash, LISTERINE® TOTAL CARE Anticavity Mouthwash, LISTERINE® WHITENING® Quick Dissolving Strips, LISTERINE® WHITENING® Pre-Brush Rinse, LISTERINE® WHITENING® VIBRANT WHITE® Pre-Brush Rinse, LISTERINE® WHITENING® Pen, LISTERINE® SMART RINSE®, LISTERINE® AGENT COOL BLUE®, REACH® toothbrushes, REACH® floss, and REMBRANDT® tooth whitening products.

About National Children's Oral Health Foundation: America's Toothfairy®

National Children's Oral Health Foundation: America's Toothfairy® is a 501(c)(3) nonprofit, dedicated to raising awareness of the #1 chronic childhood illness: pediatric dental disease, facilitating delivery of comprehensive pediatric oral health services, and eliminating this preventable disease from future generations. NCOHF draws on vast national resources to secure and distribute product and financial donations along with innovative preventive programs to a growing network of not-for-profit community-based universities, health centers, dental clinics, and mobile programs throughout America.

For more information about NCOHF, please visit

Neil Patrick Harris is a consultant for Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. and/or Johnson & Johnson's expectations and projections.  Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2010.  Copies of this Form 10-K, as well as subsequent filings, are available online at, or on request from Johnson & Johnson.  Neither Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)


Lauren Steinhorn

Kristina Chang


Johnson & Johnson

(212) 704-4455

Healthcare Products

[email protected]

Division of McNEIL-PPC, Inc.

(973) 385-4370

[email protected]

SOURCE Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.